Arvinas (ARVN) Operating Margin (QoQ) (2017 - 2026)
Arvinas (ARVN) Operating Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,629.00 |
| Dec 31, 2025 | -68,073.00 |
| Sep 30, 2025 | 21,466.00 |
| Jun 30, 2025 | -35,701.00 |
| Mar 31, 2025 | 13,613.00 |
| Dec 31, 2024 | -3,942.00 |
| Sep 30, 2024 | 451.00 |
| Jun 30, 2024 | 26,585.00 |
| Mar 31, 2024 | -71,278.00 |
| Dec 31, 2023 | 59,711.00 |
| Sep 30, 2023 | -7,670.00 |
| Jun 30, 2023 | 13,297.00 |
| Mar 31, 2023 | -6,985.00 |
| Dec 31, 2022 | -633.00 |
| Sep 30, 2022 | 100.00 |
| Jun 30, 2022 | 2,306.00 |
| Mar 31, 2022 | -7,466.00 |
| Dec 31, 2021 | 36,553.00 |
| Sep 30, 2021 | 43,503.00 |
| Jun 30, 2021 | -18,545.00 |